Previous 10 | Next 10 |
To say that things did not go as planned for marijuana stock industry in 2019 would be an accurate statement . High tax rates in select U.S. markets, and persistent supply problems throughout Canada, allowed an already resilient black market to prosper in North America. This, in turn, wound up ...
For the marijuana industry, last week was fairly eventful. The individual happenings weren't necessarily momentous, but they matter in a business that in many ways is still finding its way to success. We can break them down into two categories -- fund raising and executive shifts -- and there w...
Last year began with a mountain of promise for the cannabis industry. Canada had recently legalized recreational pot and high-margin derivatives were slated to hit dispensary shelves later in the year. Meanwhile, momentum for state-level legalizations in the U.S., the most lucrative marijuana ma...
Aphria (NYSE: APHA) was easily the best-performing Canadian marijuana stock among the top five licensed producers last year. Nonetheless, the company's stock was still a big loser in absolute terms, with its shares falling by over 8% over the course of 2019. That fact speaks volumes abo...
Though a lot of marijuana history has been made in recent years, most of it can be attributed to Canada, which became the first industrialized country in the modern era to green-light adult-use cannabis sales in October 2018. Despite the launch of recreational pot sales not going as planned -- ...
Aurora Cannabis (NYSE: ACB) and Cronos Group (NASDAQ: CRON) aren't exactly investors' favorites right now. Both stocks plunged in 2019, with Aurora sinking 56% and Cronos falling 26%. However, the situation could look better for Aurora and Cronos in 2020. Which of these two marijuana st...
Late Wednesday night, Canadian cannabis company Cronos Group (NASDAQ: CRON) filed an 8-K form with the SEC, advising that way back on Dec. 31, both its chief operating officer and its chief commercial officer resigned from the company. Now, you might expect that such a late-night...
TMX Group (TSE: X ) has launched its newest index, which tracks the performance of cannabis companies in North America trading on two of its exchanges. The S&P/TSX Cannabis Index (TSX: XCAN ) debuted on Monday (January 20), closing its first day of trading at C$230.24. As of 12:02 p.m....
TORONTO, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and Chief Executive Officer, will speak at the 23rd Annual CIBC Wes...
Cronos Group (NASDAQ: CRON) was once known as the best-performing marijuana stock of all time , and the good news for the company is that it performed better than many of its peers in 2019. The bad news for Cronos, however, is that it still didn't perform well. Sure, the company's shares s...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- FinancialBuzz.com News Commentary The breathalyzer market has experienced significant growth due to a heightened awareness of the dangers associated with impaired driving and the stringent enforcement of alcohol consumption laws globally. B...
Cronos Group Inc., (NASDAQ: CRON) a global cannabinoid company, has reported an increase in net revenue for the first quarter of 2024. The company&...
2024-05-09 13:30:17 ET Image source: The Motley Fool. Cronos Group (NASDAQ: CRON) Q1 2024 Earnings Call May 09, 2024 , 8:30 a.m. ET Operator Continue reading For further details see: Cronos Group (CRON) Q1 2024 Earnings Call Transcript